The Assessment of in Vitro Cardiotoxic Potentials for Synthetic Cannabinoid, AM-2201

Esra Nişikli, M. Akar, G. Ozhan
{"title":"The Assessment of in Vitro Cardiotoxic Potentials for Synthetic Cannabinoid, AM-2201","authors":"Esra Nişikli, M. Akar, G. Ozhan","doi":"10.26650/istanbuljpharm.2019.19004","DOIUrl":null,"url":null,"abstract":"DOI : 10.26650/IstanbulJPharm.2019.19004 Synthetic cannabinoid abuse becomes more common in recent years, although knowledge about the risk of the relatively new synthetic cannabinoid molecules is not adequate. Data is mainly limited with new analytical methods and case reports related to their clinical effects. The studies are generally related to the cardiac effects of first defined molecules rather than every molecule in the group. The cardiac clinical effects of synthetic cannabinoid abuse and underlying mechanisms are not certain. Therefore, we aimed to investigate AM-2201, one of synthetic cannabinoids, because knowledge for AM-2201 is less than the others in this group. The cardiotoxicity and underlying mechanisms of AM-2201 were assessed on cardiac cell culture. The half-maximal inhibition concentration (IC50) values were 101.49 and 63.33 M by WST-1 and LDH assays. AM-2201 was not induced either the total antioxidant capacity (TAC) or reactive oxygen species (ROS) levels. As to the measurements Annexin V-FITC and acridine orange dye, AM-2201 did not induce apoptosis and the primary cell death was necrosis. According to our results, further studies such as mechanism on cell death and cancer pathways should be investigated. You may cite this article as : Nisikli E, Celiksoz Akar M, Ozhan G (2019). The Assessment of in Vitro Cardiotoxic Potentials for Synthetic Cannabinoid, AM-2201. Istanbul J Pharm 10.26650/IstanbulJPharm.2019.19004.","PeriodicalId":14484,"journal":{"name":"İstanbul Journal of Pharmacy","volume":"50 3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"İstanbul Journal of Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26650/istanbuljpharm.2019.19004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

DOI : 10.26650/IstanbulJPharm.2019.19004 Synthetic cannabinoid abuse becomes more common in recent years, although knowledge about the risk of the relatively new synthetic cannabinoid molecules is not adequate. Data is mainly limited with new analytical methods and case reports related to their clinical effects. The studies are generally related to the cardiac effects of first defined molecules rather than every molecule in the group. The cardiac clinical effects of synthetic cannabinoid abuse and underlying mechanisms are not certain. Therefore, we aimed to investigate AM-2201, one of synthetic cannabinoids, because knowledge for AM-2201 is less than the others in this group. The cardiotoxicity and underlying mechanisms of AM-2201 were assessed on cardiac cell culture. The half-maximal inhibition concentration (IC50) values were 101.49 and 63.33 M by WST-1 and LDH assays. AM-2201 was not induced either the total antioxidant capacity (TAC) or reactive oxygen species (ROS) levels. As to the measurements Annexin V-FITC and acridine orange dye, AM-2201 did not induce apoptosis and the primary cell death was necrosis. According to our results, further studies such as mechanism on cell death and cancer pathways should be investigated. You may cite this article as : Nisikli E, Celiksoz Akar M, Ozhan G (2019). The Assessment of in Vitro Cardiotoxic Potentials for Synthetic Cannabinoid, AM-2201. Istanbul J Pharm 10.26650/IstanbulJPharm.2019.19004.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
合成大麻素AM-2201体外心脏毒性电位的评估
近年来,合成大麻素滥用变得越来越普遍,尽管对相对较新的合成大麻素分子的风险了解并不充分。数据主要局限于新的分析方法和与临床效果相关的病例报告。这些研究通常与第一个确定的分子的心脏作用有关,而不是与组中的每个分子有关。滥用合成大麻素对心脏的临床影响及其潜在机制尚不确定。因此,我们的目标是研究合成大麻素之一AM-2201,因为对AM-2201的了解比该组的其他大麻素少。在心脏细胞培养中评估AM-2201的心脏毒性及其潜在机制。WST-1和LDH的半最大抑制浓度(IC50)分别为101.49和63.33M。AM-2201不诱导总抗氧化能力(TAC)和活性氧(ROS)水平。Annexin V-FITC和吖啶橙染色检测显示,AM-2201不诱导细胞凋亡,细胞以坏死为主死亡。根据我们的研究结果,需要进一步研究细胞死亡机制和癌症途径。你可以将这篇文章引用为:Nisikli E, Celiksoz Akar M, Ozhan G(2019)。合成大麻素AM-2201体外心脏毒性电位的评估IstanbulJPharm 10.26650/ istanbuljpharma .2019.19004。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Ameliorative effect of cranberry on erectile function in diabetic rats Inhibitory potentials of Moringa oleifera on activities of neuraminidase, xanthine oxidase and adenosine deaminase A chemometrics-based approach for the determination of thymoquinone from Nigella sativa L. (Black Cumin) seeds of different geographical regions using the HPLC technique Virtual drug screening for p65/rela subunit of nf-κb: Promising repurposable drugs in the treatment of stress-based diseases Taxonomic significance of anatomy and achene micromorphology of selected Cousinia Cass. species (Asteraceae)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1